Rovida Investment Management Discloses 102 Million Stake in H World Group Amid Stock Rally UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Industry Minister US Stock Futures and Bond Yields Decline on Reports of Putins Updated Nuclear Doctrine Alcoa Stock Rallies on Analyst Upgrade as Iran Conflict Lifts Aluminum Prices UKGulf Trade Pact Described as Monumental Achievement by Bahrain Minister Faster LargeCap Entry to Russell Indexes LSEG Announces Methodology Update NXPI Q1 2026 Earnings Strong EPS Beat Drives Stock Rally CMBM Q3 2024 Earnings EPS Surprise Beat Amidst Operational Restructuring ENSC Q1 2026 Earnings Narrowerthanexpected Net Loss as EPS Beats Estimates SVV Q1 2026 Earnings Small EPS Miss But Stock Gains on Operational Resilience YETI Q1 2026 Earnings Strong EPS Surprise Drives Stock Higher SOHON Q2 2025 Earnings Preferred EPS of 021 Reported Stock Edges Lower Natures Sunshine Products NATR Slips 105 as Stock Tests Key Support Levels PTC Therapeutics PTCT Slips 140 as Biotech Sector Faces Selling Pressure Gyre Therapeutics Inc GYRE Edges Lower Testing Key Support Levels Amalgamated Financial Corp AMAL Edges Lower as Sector Headwinds Persist Valley National Bancorp Preferred Stock VLYPN Edges Higher as Yield Appeal Holds TIFINAI Expands to Australia with New Venture RILYT Q1 2024 Earnings Negative EPS Highlights Challenges for Senior Notes Holders Alibaba BABA Faces Resistance Near 136 as Shares Pull Back 119 Technical Levels in Focus Sensient Technologies SXT Q1 2026 Earnings Strong EPS Surprise Drives Stock Gain MSN Q1 2024 Earnings Reports Net Loss Amid Limited Operational Disclosure Flexible Solutions International Inc FSI Q1 2026 Earnings EPS Misses Estimates but Stock Gains 313 LDI Q1 2026 Earnings EPS Misses Estimates as Mortgage Lender Reports WiderThanExpected Loss Hyperfine Inc HYPR Q1 2026 Earnings Narrower Loss Beats Estimates Stock Declines Amid Uncertain Revenue Outlook ARHS Q1 2026 Earnings EPS Surprises to the Upside Amidst Challenging Retail Environment Evommune Inc EVMN Q1 2026 Earnings EPS Beats Estimates as PreRevenue Biotech Focuses on Pipeline Progress